Reversal of CD8 T-cell-mediated mucocutaneous graft-versus-host-like disease by the JAK inhibitor tofacitinib.
JAK抑制剂托法替尼逆转CD8 T细胞介导的黏膜皮肤移植物抗宿主样疾病
期刊:Journal of Investigative Dermatology
影响因子:5.7
doi:10.1038/jid.2013.476
Okiyama Naoko, Furumoto Yasuko, Villarroel Vadim A, Linton Jay T, Tsai Wanxia L, Gutermuth Jan, Ghoreschi Kamran, Gadina Massimo, O'Shea John J, Katz Stephen I
